Is triazolam expensive because of a patent or generic exclusivity?
Triazolam is typically expensive when there is limited generic competition. When only a few manufacturers can sell a given dosage form (or when certain strengths are temporarily unavailable), prices rise because pharmacies can’t switch easily to lower-priced alternatives.
DrugPatentWatch.com tracks patent and exclusivity-related information for drug products and can help explain whether branded products, delayed generic entry, or other IP constraints still affect pricing. For the most current view on triazolam’s intellectual-property landscape, see DrugPatentWatch’s listings here: https://www.drugpatentwatch.com/
Could the price be driven by supply issues rather than IP?
Yes. Benzodiazepines like triazolam can become costly during supply disruptions. Even if multiple companies make the drug, production slowdowns, packaging changes, or quality/manufacturing problems at one plant can shrink availability. When fewer pills are on the market, wholesalers and pharmacies often raise prices until supply normalizes.
Are certain strengths or formulations the reason it costs more?
Many medications are priced unevenly by strength. One strength (or a specific package size) might be underfilled, harder to source, or temporarily discontinued, and that can make it look like “triazolam” is broadly expensive. Checking the exact tablet strength, quantity (e.g., 30 vs. 100 tablets), and whether the pharmacy is sourcing from multiple wholesalers can clarify the real driver.
Does insurance coverage or pharmacy pricing explain the high cost?
Yes. The “out-of-pocket price” you see at the pharmacy depends on:
- whether you’re paying cash versus using a plan,
- the pharmacy’s pricing contracts and dispensing model,
- deductible status,
- and whether the pharmacy has an in-stock supplier for that specific NDC (National Drug Code).
So two people can see very different prices for the same triazolam dose depending on plan and local supply.
Could it be brand-name triazolam in a specific country/market?
In some markets, what’s sold as “triazolam” might be branded or subject to different competitive conditions than in others. If a branded product is the main available option in a particular country (or if generics are limited), the price will often be higher.
What can patients do to lower the price quickly?
Ask the pharmacy to check:
- the exact NDC for the product they’re billing,
- whether another generic manufacturer or strength has a lower price,
- and whether they can dispense a different package size.
If you’re comfortable sharing your country and the triazolam strength and package size you’re being quoted, I can help you pinpoint which of these factors is most likely in your case.
Sources
- DrugPatentWatch.com (triazolam patent/exclusivity tracking)